In accordance with public notice requirements established at 42 CFR 447.205 of the Social Security Act, the Indiana Family and Social Services Administration, Office of Medicaid Policy and Planning (OMPP) publishes this notice of proposed changes to methods and standards governing the Medicaid drug utilization review program. This public notice period will run 11/27/2019-12/27/2019.

OMPP proposes to implement additional drug utilization review (DUR) provisions in accordance with the federal Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act. This change shall be effective October 1, 2019.

OMPP is making the change in order comply with Section 1004 of the SUPPORT Act. This change brings the state plan into alignment with existing state policy; therefore, there is no fiscal impact associated with this change.

A copy of this notice is now on file at the Indiana Government Center South, 402 West Washington Street, Room W451, Indianapolis, Indiana and is open for public inspection. Also, a copy of this notice is now available and may be inspected by contacting the local county Division of Family Resources office, except in Marion County, where public inspection may be made at 402 West Washington Street, Room W374, Indianapolis, Indiana.

There will be no public hearing. Written comments may be directed to FSSA, Office of Medicaid Policy and Planning, Attention: Marc Shirley, 402 West Washington Street, Room W382, P.O. Box 7083, Indianapolis, IN 46207-7083 or by email to spacomments@fssa.in.gov. Correspondence should be identified in the following manner: COMMENT RE: DRUG UTILIZATION REVIEW PROVISIONS. Written comments will be made available for public inspection at the address herein of the OMPP.

Jennifer Sullivan, MD, MPH

Secretary

Family and Social Services Administration